SAREPTA THERAPEUTICS, INC. Acquisitions, Net of Cash Acquired
SAREPTA THERAPEUTICS, INC. (SRPT) reported Acquisitions, Net of Cash Acquired of $172.56 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2022-03-01
- SAREPTA THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-12-31 was $0.00.
- SAREPTA THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-09-30 was $0.00.
- SAREPTA THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2019 was $172.56M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 395 month | Payments to Acquire Businesses, Net of Cash Acquired 398 month | Payments to Acquire Businesses, Net of Cash Acquired 401 month | Payments to Acquire Businesses, Net of Cash Acquired 404 month |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $172.56M 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $172.56M 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | $172.56M 10-Q · filed 2020-08-05 | |||||||
| 2014-03-31 | $2.39M 10-Q · filed 2014-05-08 | |||||||
| 2013-12-31 | $2.39M 10-K · filed 2014-03-03 | |||||||
| 2013-09-30 | $2.39M 10-Q · filed 2013-11-12 | |||||||
| 2013-06-30 | $2.39M 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |